The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(3,4-Dihydroxyphenyl)-N-butylacrylamide ID: ALA4102174
Chembl Id: CHEMBL4102174
PubChem CID: 15086373
Max Phase: Preclinical
Molecular Formula: C13H17NO3
Molecular Weight: 235.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCNC(=O)/C=C/c1ccc(O)c(O)c1
Standard InChI: InChI=1S/C13H17NO3/c1-2-3-8-14-13(17)7-5-10-4-6-11(15)12(16)9-10/h4-7,9,15-16H,2-3,8H2,1H3,(H,14,17)/b7-5+
Standard InChI Key: HWCLPNBZZHKVDI-FNORWQNLSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 235.28Molecular Weight (Monoisotopic): 235.1208AlogP: 2.03#Rotatable Bonds: 5Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.22CX Basic pKa: ┄CX LogP: 2.27CX LogD: 2.26Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.42Np Likeness Score: 0.34
References 1. Moosavi F, Hosseini R, Rajaian H, Silva T, Magalhães E Silva D, Saso L, Edraki N, Miri R, Borges F, Firuzi O.. (2017) Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents., 25 (12): [PMID:28495385 ] [10.1016/j.bmc.2017.04.026 ]